by Harry Alexander | Nov 8, 2022 | Healthcare, Innovation Prize
Existing clinical pathways for eyecare are overwhelmed with the significant backlog of patients in secondary care. Before the C-19 pandemic, four million patients in the UK were referred to hospitals but had not been treated within 18 weeks. Further, a pause on...
by Harry Alexander | Oct 24, 2022 | Healthcare, Portfolio
We’re happy to announce that QantX have completed an investment into Watercress Research, a pioneering startup developing processes to extract clinically useful products from the peppery salad leaf, watercress (Nasturtium Officinale). Watercress, a member of the...
